Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aveanna Healthcare Holdings (AVAH) Revenue (2020 - 2026)

Aveanna Healthcare Holdings (AVAH) has disclosed Revenue for 6 consecutive years, with $621.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Revenue rose 22.18% year-over-year to $621.9 million, compared with a TTM value of $2.3 billion through Sep 2025, up 15.48%, and an annual FY2024 reading of $2.0 billion, up 6.82% over the prior year.
  • Revenue was $621.9 million for Q3 2025 at Aveanna Healthcare Holdings, up from $589.6 million in the prior quarter.
  • Across five years, Revenue topped out at $714.8 million in Q4 2022 and bottomed at $411.3 million in Q4 2021.
  • Average Revenue over 5 years is $500.4 million, with a median of $478.4 million recorded in 2023.
  • The sharpest move saw Revenue soared 21746.11% in 2021, then tumbled 33.01% in 2023.
  • Year by year, Revenue stood at $411.3 million in 2021, then soared by 73.81% to $714.8 million in 2022, then crashed by 33.01% to $478.8 million in 2023, then increased by 8.57% to $519.9 million in 2024, then rose by 19.63% to $621.9 million in 2025.
  • Business Quant data shows Revenue for AVAH at $621.9 million in Q3 2025, $589.6 million in Q2 2025, and $559.2 million in Q1 2025.